These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
441 related articles for article (PubMed ID: 8968214)
1. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies. van der Meché FG; van Doorn PA Ann Neurol; 1995 May; 37 Suppl 1():S14-31. PubMed ID: 8968214 [TBL] [Abstract][Full Text] [Related]
2. Future developments in the treatment of immune-mediated polyneuropathies. van der Meché FG; van Doorn PA Eur Neurol; 1997; 38(3):230-7. PubMed ID: 9363836 [TBL] [Abstract][Full Text] [Related]
10. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Gorson KC; Allam G; Ropper AH Neurology; 1997 Feb; 48(2):321-8. PubMed ID: 9040714 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of chronic immune-mediated polyneuropathies. State of the art and perspectives]. Léger JM; Chassande B Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S19-23. PubMed ID: 10896984 [TBL] [Abstract][Full Text] [Related]
12. Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathies. Lehmann HC; Hartung HP J Neuroimmunol; 2011 Feb; 231(1-2):61-9. PubMed ID: 21056913 [TBL] [Abstract][Full Text] [Related]
13. The mechanism of action of intravenous immunoglobulin in patients with chronic inflammatory demyelinating polyneuropathy. Brand A; Van Doorn PA; Rossi F; Kazatchkine MD; Vermeulen M Prog Clin Biol Res; 1990; 337():405-9. PubMed ID: 2353004 [No Abstract] [Full Text] [Related]
14. Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies. Lim JP; Devaux J; Yuki N Autoimmun Rev; 2014 Oct; 13(10):1070-8. PubMed ID: 25172243 [TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin treatment in multifocal motor neuropathy and other chronic immune-mediated neuropathies. Comi G; Nemni R; Amadio S; Galardi G; Leocani L Mult Scler; 1997 Apr; 3(2):93-7. PubMed ID: 9291161 [TBL] [Abstract][Full Text] [Related]
16. Treatment of autoimmune neuromuscular diseases with high-dose intravenous immune globulin. Soueidan SA; Dalakas MC Pediatr Res; 1993 Jan; 33(1 Suppl):S95-100. PubMed ID: 8433882 [TBL] [Abstract][Full Text] [Related]
18. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Enders U; Karch H; Toyka KV; Michels M; Zielasek J; Pette M; Heesemann J; Hartung HP Ann Neurol; 1993 Aug; 34(2):136-44. PubMed ID: 8338338 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of high-dose intravenous immunoglobulins in demyelinating diseases. Stangel M; Toyka KV; Gold R Arch Neurol; 1999 Jun; 56(6):661-3. PubMed ID: 10369303 [TBL] [Abstract][Full Text] [Related]
20. [Recent acquisitions in the treatment of chronic immune-mediated polyneuropathies]. Léger JM; Viala K Rev Neurol (Paris); 2004 Feb; 160(2):205-10. PubMed ID: 15034478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]